Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Revive Therapeutics's share price for the quarter that ended in Dec. 2023 was C$0.03. Revive Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 358.45 Mil. Therefore, Revive Therapeutics's market cap for the quarter that ended in Dec. 2023 was C$10.75 Mil.
Revive Therapeutics's quarterly market cap
declined
from Jun. 2023 (C$16.09 Mil) to Sep. 2023 (C$14.31 Mil) and
declined
from Sep. 2023 (C$14.31 Mil) to Dec. 2023 (C$10.75 Mil).
Revive Therapeutics's annual market cap
declined
from Jun. 2021 (C$187.60 Mil) to Jun. 2022 (C$147.86 Mil) and
declined
from Jun. 2022 (C$147.86 Mil) to Jun. 2023 (C$16.09 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Revive Therapeutics's Enterprise Value for Today is C$8.41 Mil.
Revive Therapeutics Market Cap Historical Data
The historical data trend for Revive Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Revive Therapeutics's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revive Therapeutics's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Revive Therapeutics's Market Cap falls into.
Revive Therapeutics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Revive Therapeutics's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revive Therapeutics (XCNQ:RVV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Revive Therapeutics Market Cap Related Terms
Thank you for viewing the detailed overview of Revive Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Revive Therapeutics (XCNQ:RVV) Business Description
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:RVV has been successfully added to your 